Core Viewpoint - The company, Gilead Sciences-B (01672), announced the issuance of 98,000 ordinary shares due to eligible participants exercising stock options under the stock option plan adopted on June 6, 2019 [1] Group 1 - The total number of ordinary shares to be issued is 98,000 [1] - The stock option plan was adopted on June 6, 2019 [1] - The issuance date for the shares is set for September 10, 2025 [1]

Group 1 - The company, Neway Group (01686), announced the issuance of 20,000 shares due to the exercise of stock options [1] - The stock options were granted under a stock option plan adopted on November 1, 2022 [1] - The exercise date for the stock options is set for September 10, 2025 [1]

Core Viewpoint - 嘉利国际 (01050) has announced the decision to grant a total of 73.38 million stock options under its stock option plan adopted on August 30, 2023, to the grantees, which will allow them to subscribe for up to 73.38 million ordinary shares of the company at a par value of HKD 0.1 per share, pending acceptance by the grantees [1]. Summary by Relevant Sections - Stock Option Plan - The company has adopted a stock option plan on August 30, 2023, which allows for the issuance of stock options to grantees [1]. - A total of 73.38 million stock options will be granted, enabling the subscription of an equal number of ordinary shares [1]. - Grant Date - The stock options will be granted on September 4, 2025, which is the designated grant date [1]. - Acceptance Requirement - The grant of stock options is contingent upon acceptance by the grantees, meaning the options will only become effective once accepted [1].

Group 1 - The company announced the issuance of 684,100 shares due to the vesting of restricted share units under the 2023 Restricted Share Unit Plan adopted on October 27, 2023 [1] - The company issued 906,600 shares as a result of the exercise of stock options by the CEO under the 2023 Stock Option Plan [1] - Additionally, 284,400 shares were issued due to the exercise of stock options by eligible employees under the post-IPO Stock Option Plan [1]

Group 1 - The company, Heart Company (02400), announced the issuance of a total of 309,300 ordinary shares due to eligible participants exercising stock options under the stock option plan adopted on June 25, 2021 [1]

Core Viewpoint - Yunfeng Financial (00376) announced the proposal to adopt a new share award plan for 2025, which will replace the existing 2016 share award plan set to expire in December 2026, pending shareholder approval [1] Group 1: Share Award Plans - The 2025 Share Award Plan is designed to encourage eligible participants, including employees and service providers, to hold shares and align their interests with those of shareholders [1] - The board also proposed amendments to the 2022 Share Option Plan to ensure compliance with revised listing rules, allowing the use of the company's treasury shares for option settlements [1]

Core Viewpoint - The company proposes a 2025 stock option plan aimed at attracting and retaining top talent, providing additional rewards for eligible participants, and promoting overall business success [1] Group 1 - The 2025 stock option plan will be effective for 10 years from the date of adoption [1] - The plan is designed to offer eligible participants the opportunity to have personal equity in the company, which will help motivate them to improve performance and efficiency [1] - The initiative aims to attract and retain participants who significantly contribute to the company's long-term growth and profitability [1]

Core Viewpoint - The company proposes a 2025 stock option plan aimed at attracting and retaining top talent, providing additional rewards for eligible participants, and promoting overall business success [1] Group 1 - The 2025 stock option plan will be effective for 10 years from the date of adoption [1] - The plan is designed to offer eligible participants the opportunity to have personal equity in the company, which will help motivate them to improve performance and efficiency [1] - The initiative aims to attract and retain participants who significantly contribute to the company's long-term growth and profitability [1]

Group 1 - The shareholders of PACIFIC LEGEND (08547) transferred stocks from Huazhong Securities Hong Kong to Baoxin Securities, with a market value of 8.7003 million HKD, representing 6.73% of the total [1] - PACIFIC LEGEND announced the grant of a total of 10 million stock options to eligible participants, which will allow them to subscribe for 10 million shares at a par value of 0.1 HKD per share, pending acceptance by the participants [1]

Group 1 - The company, Yuewen Group (00772), announced the issuance of a total of 265,500 shares on August 18, 2025, as part of the exercise of stock options under the 2021 Share Option Scheme approved on May 24, 2021, and revised on May 22, 2023 [1]